Solution Partners

Carmat is a leader in health innovation, aiming to save the lives of patients with advanced heart failure and improve their quality of life, offering pioneering and life-changing technologies to cardiologists.

Impulse Dynamics is a rapidly growing medical device company that has developed Cardiac Contractility Modulation (CCM®) therapy, a breakthrough treatment for chronic heart failure. Delivered through the Optimizer® Smart Mini systems, this FDA-approved therapy, recognized as a “Breakthrough Device,” improves quality of life and functional status in many heart failure patients.

It is revolutionizing cardiovascular implantable devices with a polymer platform and a new design approach.

Redesigning solutions for heart failure (HF) patients with a completely different treatment approach to help patients live longer, higher-quality lives.

REVA Medical is a leader in bioresorbable polymer technologies for vascular applications. Its mission is to develop and sell implantable medical devices using biomaterials, thereby improving patients' health for a lifetime.

Pulsecath enables physicians to perform rapid, safe, and effective interventions during critical moments by providing innovative solutions for temporary mechanical circulatory support in high-risk cardiac patients. In doing so, it enhances treatment success and significantly improves patients’ quality of life.

Veryan used its expertise in research and development and understanding of rotational flow to design, develop, and patent the highly innovative three-dimensional (3D), nitinol BioMimics 3D Vascular Stent System.

Are you looking for single-use radiofrequency catheters? We offer a wide range of intuitive monopolar RF generators and related consumables to treat a variety of conditions.

We are constantly working to develop innovative technologies and refine the care of cardiovascular diseases.

Rapid Medical is a company that develops innovative medical devices for the treatment of neurovascular diseases such as ischemic stroke and brain aneurysm. Its standout products include high-performance devices like Tigertriever and Comaneci.

Translumina is available in over 50 countries worldwide and has enriched the lives of more than 1 million patients.

A significant innovation in the treatment of coronary artery disease, DynamX represents one of the most significant breakthroughs in coronary implant design in the past 30 years. The future of vascular intervention won’t just evolve, it will adapt.